Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +37.44%
#3 Glidr Glidr +35.94%
#4 Humanity Humanity +25.03%
#5 Tutorial Tutorial +21.66%
#6 Enso Enso +21.56%
#7 Codatta Codatta +19.97%
#8 Walrus Walrus +19.47%
#9 BOOK OF MEME BOOK OF MEME +18.59%
#10 Ribbita by Virtuals Ribbita by Virtuals +13.44%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Relevium Technologies Inc. Relevium Technologies Inc.

Relevium Technologies Inc.

RLLVF
Clasificación en acciones #37146
Relevium Technologies Inc. operates within the health and wellness sector,... Relevium Technologies Inc. operates within the health and wellness sector, focusing on identifying, assessing, acquiring, and managing various brands and businesses, primarily through e-commerce channels. The company distributes a range of products, including dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, mainly through its Bioganix online brand. It also offers dietary supplements under the LeefyLyfe label and skincare solutions marketed as the Push & Pull System. Additionally, Relevium has developed specialized lines such as Relevium Senior, aimed at older adults for inflammatory conditions affecting joints, heart, and brain, and Relevium Kids, providing nutraceuticals and oral nutritional supplements for children. Headquartered in Montreal, Canada, the company was formerly known as BIOflex Technologies Inc. until it rebranded to Relevium Technologies Inc. in December 2015.
Precio por acción
$0.006
Última sincronización: 2026-08-13
Capitalización bursátil
$1.98M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CA
Comercio Relevium Technologies Inc. (RLLVF)

Categoría

Healthcare
Ganancias de Relevium Technologies Inc. (RLLVF)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Relevium Technologies Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Relevium Technologies Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US